Literature DB >> 26283575

Genetic evaluation of patients with Alström syndrome in the Polish population.

A Zmyslowska1, M Borowiec2, K Antosik2, R Ploski3, M Ciechanowska4, B Iwaniszewska5, A Jakubiuk-Tomaszuk6, W Janczyk7, M Krawczynski8, B Salmonowicz9, M Stelmach4, W Mlynarski1.   

Abstract

Alström syndrome (AS) is a rare syndromic form of obesity and type 2 diabetes (T2D) in children coexisting with retinal dystrophy and disorders of many organs caused by the mutations in ALMS1 gene. Aim of this study was to identify the causative mutations in ALMS1 in a group of 12 patients of Polish origin with clinical symptoms of AS, and their 21 first-degree relatives. Using DNA sequencing, nine different mutations including three novel were identified. These mutations were not present in 212 Polish individuals with no symptoms of AS, subjected to whole-exome sequencing and collected in a national registry. Looking for genotype-phenotype relationships, we confirmed a severe phenotype in a boy with homozygous mutation in exon 16, and a relationship between a presence of T2D and mutations in exon 19. Evaluation of the type of mutation and its clinical effects gives hope for earlier diagnosis of AS in future patients and more advanced therapeutic approaches for patients with already diagnosed AS.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ALMS1 gene; Alström syndrome; monogenic diabetes; novel mutations

Year:  2015        PMID: 26283575     DOI: 10.1111/cge.12656

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

1.  Identification of bone metabolism disorders in patients with Alström and Bardet-Biedl syndromes based on markers of bone turnover and mandibular atrophy.

Authors:  Krzysztof Jeziorny; Ewa Zmyslowska-Polakowska; Krystyna Wyka; Aleksandra Pyziak-Skupień; Maciej Borowiec; Agnieszka Szadkowska; Agnieszka Zmysłowska
Journal:  Bone Rep       Date:  2022-07-01

2.  Next-Generation Sequencing in the Diagnosis of Patients with Bardet-Biedl Syndrome-New Variants and Relationship with Hyperglycemia and Insulin Resistance.

Authors:  Krzysztof Jeziorny; Karolina Antosik; Paulina Jakiel; Wojciech Młynarski; Maciej Borowiec; Agnieszka Zmysłowska
Journal:  Genes (Basel)       Date:  2020-10-29       Impact factor: 4.096

3.  Alström syndrome with a novel mutation of ALMS1 and Graves' hyperthyroidism: A case report and review of the literature.

Authors:  Juan-Juan Zhang; Jun-Qi Wang; Man-Qing Sun; Yuan Xiao; Wen-Li Lu; Zhi-Ya Dong
Journal:  World J Clin Cases       Date:  2021-05-06       Impact factor: 1.337

4.  Molecular and Phenotypic Expansion of Alström Syndrome in Chinese Patients.

Authors:  Qianwen Zhang; Yu Ding; Biyun Feng; Yijun Tang; Yao Chen; Yirou Wang; Guoying Chang; Shijian Liu; Jian Wang; Qian Li; Lijun Fu; Xiumin Wang
Journal:  Front Genet       Date:  2022-02-08       Impact factor: 4.599

5.  Genetic analysis resolves differential diagnosis of a familial syndromic dilated cardiomyopathy: A new case of Alström syndrome.

Authors:  Barbara Lombardo; Valeria D'Argenio; Emanuele Monda; Andrea Vitale; Martina Caiazza; Lucia Sacchetti; Lucio Pastore; Giuseppe Limongelli; Giulia Frisso; Cristina Mazzaccara
Journal:  Mol Genet Genomic Med       Date:  2020-05-12       Impact factor: 2.183

6.  Whole exome sequencing identifies rare biallelic ALMS1 missense and stop gain mutations in familial Alström syndrome patients.

Authors:  Naglaa M Kamal; Ahmed N Sahly; Babajan Banaganapalli; Omran M Rashidi; Preetha J Shetty; Jumana Y Al-Aama; Noor A Shaik; Ramu Elango; Omar I Saadah
Journal:  Saudi J Biol Sci       Date:  2019-09-11       Impact factor: 4.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.